Tag: AM-101

3 posts with this tag

AM101 Phase 3

Written by AudioNotch Team on August 30, 2014

Categories: Tinnitus Research

Tags: AM-101 AM101 phase 3 clinical trials


AM101, a drug for treating the acute development of tinnitus, is entering Phase 3 clinical trials. Auris Medical today announced enrollment of the first patient into the TACTT2 1 clinical trial. This phase 3 trial will evaluate the efficacy, safety and tolerability of intratympanic injections of AM-101 in the treatment...

Continue Reading →

Buy AM 101 Tinnitus

Written by AudioNotch Team on August 30, 2014

Categories: Tinnitus Research

Tags: AM-101 buy AM 101 tinnitus Tinnitus


AM 101 is a drug currently in clinical trials for the treatment of tinnitus. A press release explains how it functions: AM-101 is a small molecule N-methyl-D-aspartate (NMDA) receptor antagonist formulated in a biocompatible gel for intratympanic injection. Emerging evidence suggests that NMDA receptors in the cochlea...

Continue Reading →

AM-101 Tinnitus Results

Written by AudioNotch Team on July 23, 2014

Categories: TinnitusTinnitus Research

Tags: AM-101 AM-101 tinnitus results tinnitus research


Some of you may be aware of a new drug in development for the treatment of acute tinnitus acquired due to noise trauma. Noise trauma actually kills inner ear hair cells not via direct physical trauma, but via excitotoxicity from an increase in glutamate neurotransmitters. The AM-101 drug is designed to specifically...

Continue Reading →